RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,556,380 | -33.0% | 185,063 | 0.0% | 0.56% | -32.2% |
| Q2 2023 | $2,324,391 | -23.7% | 185,063 | 0.0% | 0.82% | -29.6% |
| Q1 2023 | $3,047,988 | +10.2% | 185,063 | 0.0% | 1.17% | +2.3% |
| Q4 2022 | $2,764,841 | -33.2% | 185,063 | 0.0% | 1.14% | -34.5% |
| Q3 2022 | $4,140,000 | +33.5% | 185,063 | 0.0% | 1.75% | +30.7% |
| Q2 2022 | $3,100,000 | -44.0% | 185,063 | 0.0% | 1.34% | -31.3% |
| Q1 2022 | $5,539,000 | -2.5% | 185,063 | 0.0% | 1.94% | +4.6% |
| Q4 2021 | $5,683,000 | -2.6% | 185,063 | 0.0% | 1.86% | -7.3% |
| Q3 2021 | $5,835,000 | -13.8% | 185,063 | 0.0% | 2.00% | -10.5% |
| Q2 2021 | $6,771,000 | +5.8% | 185,063 | 0.0% | 2.24% | -4.8% |
| Q1 2021 | $6,398,000 | -7.1% | 185,063 | +11.7% | 2.35% | -13.3% |
| Q4 2020 | $6,884,000 | -2.4% | 165,639 | 0.0% | 2.71% | -18.6% |
| Q3 2020 | $7,055,000 | – | 165,639 | – | 3.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |